MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
How Houston's Manufacturing Sector Is Staying Ahead and Why Leeco Spring International Remains the Go-To Precision Spring Manufacturer
Via Press Release Distribution Service
Topics Economy Product Recall Supply Chain
Exposures Economy Legal Product Safety
News headline image
Why Eli Lilly Stock Flopped on Friday ↗
Via The Motley Fool
Tickers IQV LLY NVO
Exposures Product Safety
News headline image
Why Eli Lilly (LLY) Shares Are Trading Lower Today
Via StockStory
Topics Artificial Intelligence
Tickers LLY
Exposures Artificial Intelligence Product Safety
News headline image
FDA Flags High-Risk Recall For Tandem Diabetes Mobi Pumps ↗
Via Benzinga
Exposures Product Safety
News headline image
What's Going On With Enveric Biosciences Stock On Friday? ↗
Via Benzinga
Topics Derivatives
Exposures Derivatives Product Safety
News headline image
Grace Therapeutics Stock Falls As FDA Declines To Approve Brain Hemorrhage Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
What Nobody Tells You About Choosing a Rapid Prototyping Supplier (Until You’ve Made the Expensive Mistake)
Via Worldnewswire
Topics Supply Chain
Exposures Product Safety Supply Chain
News headline image
AbbVie Faces FDA Rejection On Manufacturing Issues For Wrinkle Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026) ↗
Via The Motley Fool
Tickers AGIO NVO
Exposures Product Safety
News headline image
1 Cash-Producing Stock to Target This Week and 2 Facing Challenges
Via StockStory
Tickers DXCM ERII LFST
Exposures Product Safety
News headline image
Trump Backs Psychedelics. Here's 1 Company Investors Need to Know About ↗
Via The Motley Fool
Topics Government
Tickers CMPS
Exposures Political Product Safety
News headline image
CCHR Says New OIG Report Raises Concerns about Drugging Elderly with Antipsychotics
Via PRLog
Exposures Product Safety
News headline image
LGBTQ+ Addiction & Mental Health Program To Open In Chicago's "Boystown"
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
News headline image
Institutional Literacy Expert Shannon Kacherovich of Lorem Springs Addresses FDA Drug Approval Literacy in Latest Xraised Episode
Via Press Release Distribution Service
Exposures COVID-19 Product Safety
News headline image
FDA to Review Wider Access to Popular Peptides — And Patients Are Already Asking What It Could Mean Next. California Trim Clinic Breaks Down the Questions Behind the Momentum
Via PRUnderground
Exposures Product Safety
News headline image
FDA Approval Broadens Dupixent Use While Sanofi Posts Earnings Beat ↗
Via Benzinga
Topics Earnings
Exposures Financial Product Safety
News headline image
Curtana Pharmaceuticals Receives FDA Rare Pediatric Disease Designation for CT-179 in Pediatric High-Grade Glioma
Via PRLog
Exposures Product Safety
News headline image
Mark Stephen McCollum Advocates for Stronger Execution and System Adoption in Automotive Retail
Via 24-7 Press Release
Topics Product Recall
Exposures Legal Product Safety
News headline image
The Sound of Serenity Quantum Healing Arts Introduces Ketamine-Assisted Meditation Events Through New Studio Partnership
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Emergent (EBS) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Topics Bonds
Tickers EBS
Exposures Debt Markets Product Safety
News headline image
The Higgins Firm Investigating Dupixent Claims After FDA Flags Skin Cancer Risk
Via PRUnderground
Topics Lawsuit
Exposures Financial Legal Product Safety
News headline image
Agios (AGIO) Q3 2024 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers AGIO
Exposures Financial Product Safety
News headline image
Positive FDA Response on Preservative-Free Ketamine After President Trump Orders Accelerated Approval for Psychedelic Medication Developers Including NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Topics Government
Tickers NRXP
Exposures Political Product Safety
News headline image
Incyte (INCY) Q4 2024 Earnings Transcript ↗
Via The Motley Fool
Tickers INCY
Exposures Product Safety
News headline image
GE HealthCare (GEHC) Q4 2024 Earnings Transcript ↗
Via The Motley Fool
Tickers GEHC
Exposures Product Safety
News headline image
Axogen (AXGN) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
Tickers AXGN
Exposures Product Safety
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives Positive FDA Review Letter Supporting Ketamine ANDA Progress
Via Investor Brand Network
Tickers BMWYY NRXP
Exposures Product Safety
News headline image
VPR Brands Retains McAndrews, Held & Malloy as Lead Patent Counsel for US Patent No. 8,205,622 B2
Via NewMediaWire
Topics Intellectual Property
Tickers VPRB
Exposures Intellectual Property Product Safety
VPR Brands Retains McAndrews, Held & Malloy as Lead Patent Counsel for US Patent No. 8,205,622 B2
Via TheNewswire.com
Topics Intellectual Property
Tickers VPRB
Exposures Intellectual Property Product Safety
News headline image
Why Intuitive Surgical Stock Soared Today ↗
Via The Motley Fool
Tickers ISRG
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story